Embodiments relate generally to drug delivery infusion profiles for infusion pumps and, more particularly, to drug delivery profiles that can be transferred, edited, and executed on infusion pump systems without a need for loading new firmware.
Infusion pumps are extremely useful medical devices for managing the delivery and dispensation of therapeutic medications. Infusion pumps provide significant advantages over manual administration by accurately delivering medications over an extended period of time. Infusion pumps are particularly useful for treating diseases and disorders that require regular pharmacological intervention, including cancer, diabetes, and vascular, neurological, and metabolic disorders. They also enhance the ability of healthcare providers to deliver anesthesia and manage pain. Infusion pumps are used in various settings, including hospitals, nursing homes, and other short-term and long-term medical facilities, as well as in residential care settings. There are many types of infusion pumps, including ambulatory, large volume, patient-controlled analgesia (PCA), elastomeric, syringe, enteral, and insulin pumps. Infusion pumps can be used to administer medication through various delivery methods, including intravenously, intraperitoneally, intra-arterially, intradermally, subcutaneously, in close proximity to nerves, and into an intraoperative site, epidural space or subarachnoid space.
Typically, infusion pumps are locally controlled via the programming of the individual infusion pump. For example, a physician can configure an infusion pump to execute a delivery profile that corresponds to a patient's treatment needs, or a patient can configure an infusion pump according to their individual requirements within pre-defined limits without the involvement of a physician. Generally, an infusion pump is programmed or configured according to certain physiological, pharmacokinetic, and operational parameters or limits that are often predefined. In recent years, infusion pumps have become increasingly sophisticated and may include such features as dose error reduction software, which enable infusion pumps to perform functions that assist healthcare providers with programming and calculating dose and delivery rates in an effort to reduce medication errors and potentially consequential harm to the patient. Infusion pumps can also be programmed or configured to access databases (often referred to as “drug libraries”) containing information relating to medications that can be used with that pump, as well as information corresponding to dosing guidelines, drug concentrations, dose limits, and clinical advisories. Such features can include computer- and/or server-based software that creates, configures or otherwise provides medication safety software settings. These features may generally enable healthcare providers to select medications from pre-loaded lists, which can be tailored to each healthcare facility and patient care area. Additionally, healthcare facilities can integrate infusion pumps with electronic medical records, computerized order entry systems, and medication recognition systems, such as, e.g., barcode scanning systems, to further enhance safety and efficacy. Healthcare facilities can also choose to generally and/or specifically implement dosing and delivery limitations, commonly called hard and soft limits, on preselected drugs.
As infusate therapies advance, there is a correspondingly increased need for infusion pumps that accommodate the evolving needs of patients, healthcare providers, and healthcare facilities. Improved infusion pump systems and methods should have the capability to integrate existing information concerning drug protocols and delivery profiles with new drugs and delivery profiles in a manner that is convenient and not dependent on a specific device or technology. Additionally, improved infusion pump systems and methods should have the capability to transition between different infusion pump protocols and mimic or emulate the protocols and regimes employed by various infusion pump manufacturers.
It would therefore be advantageous to provide an ability to access and download a database of information with which to execute delivery protocols for infusion pumps without the need for loading new firmware. It would also be advantageous to have an ability to readily transfer predefined infusion profiles, and edit and/or integrate the profiles, in order to adapt to changes in technology and pharmacology.
Embodiments described or otherwise contemplated herein substantially meet the aforementioned needs; for example, providing methods and systems for creating, integrating, editing, and storing infusion pump delivery profiles and profile segments. In an embodiment, an infusion pump is configured with subsystem software to download, edit, and execute infusion profiles or profile segments without a need for loading new firmware.
In an embodiment, predefined delivery profiles, such as target-controlled infusion (TCI) profiles and information relating delivery profiles can be collected and stored in a database or library. Embodiments of the database can include information relating to, for example, various drugs and pharmacokinetic parameters used to execute delivery protocols for use in an infusion pump context. Embodiments can include predefined delivery profiles, such as TCI profiles that can be transferred to an infusion pump, edited, and/or integrated and then executed on the infusion pump, without limitations as to the source of the delivery profiles or the manufacturer of the device typically used to execute the delivery protocols. In other embodiments, the delivery profiles can be segmentable, such that the user of an infusion pump can transfer entire profiles or segments of profiles to an infusion pump. One skilled in the art will readily understand that reference to TCI profiles throughout this disclosure is simply an exemplary embodiment used as an example, and is not intended to limit the scope, applicability, or configuration of the invention in any way. Rather, TCI is one example of the disclosure herein describing the adjustment of delivery profiles with respect to various parameters and/or behaviors of various infusates.
In a feature and advantage of embodiments, a user can integrate general or specific delivery profiles, or segments of delivery profiles, to create segmented delivery profiles, which can then be edited using the infusion pump. For example, each profile segment can be defined with a name, a set of delivery shape parameters, and/or user-defined parameters, which can be used as an underlying template for execution of delivery profiles or segments thereof, commonly supported by infusion pumps and associated systems. A user can alter a delivery profile by changing the coefficients of its underlying polynomial equation, or by adjusting the curve of the profile by interacting with a user interface (i.e., a touchscreen or keypad) on an infusion pump. In an embodiment, the delivery profiles created by a user can be stored on the infusion pump, or uploaded to a server for a database of other delivery profiles. Embodiments allow healthcare providers and medical device companies to respond quickly to changes in infusion pump technology, drug development, and pharmacokinetics by providing the ability to create, edit, integrate, and store delivery profiles to accommodate these changes.
The above summary is not necessarily intended to describe each illustrated embodiment or every implementation of the subject matter hereof. The figures and the detailed description that follow more particularly exemplify these embodiments.
Subject matter hereof may be more completely understood in consideration of the following detailed description of various embodiments of the subject matter in connection with the accompanying drawings, in which:
While embodiments are amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit subject matter hereof to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of subject matter hereof in accordance with the appended claims.
Infusion pump 150 shown in
In embodiments, each segment can be defined with a name, a set of delivery shape parameters, machine readable code, and/or user-defined parameters, which can be used as an underlying template for the execution of delivery protocols commonly supported by infusion pump devices (e.g., TCI, PCA, Total Parenteral Nutrition (TPN) tapers, Insulin on-board corrections, Intermittent Volume Over Time (IVOT), Boluses, etc.). Infusion pump profiles and segments of profiles (e.g., represented graphically in the examples of
As shown in
In further embodiments, the user of infusion pump 540 can connect either to computer management system 530 or to server 520 to transfer, edit, and/or integrate drug delivery profiles or segments of profiles using infusion pump 540. A user can create a segmented delivery profile or a group of segmented delivery profiles that can be saved locally in user file 550 of infusion pump 540, or uploaded to server 520 or computer management system 530.
In embodiments, databases or drug libraries 510 can be stored as encrypted files or be part of an open source or other platform. A set of drugs within drug libraries 510 can, for example, be selected to be representative of the range of drugs used in healthcare facilities. The subsystem software can include an application program providing a user interface that enables an authorized individual (i.e., one with authorized password and access level) to transfer, edit, or integrate drug delivery profiles or segments of profiles specific to that user. Such user-generated drug delivery profiles can be stored as user files 550. Users of computer management system 530 can oversee user-generated delivery profiles as well as transfer, edit, and/or integrate drug delivery profiles or segments of profiles. Computer management system 530 can create or aggregate a customized library of drug delivery profiles for use, for example, at a specific pharmacy or healthcare facility. In embodiments, computer management system 530 can aggregate libraries of predefined delivery profiles executed on various infusion pumps from various different manufacturers. In further embodiments, computer management system 530 can create, edit, or integrate a library of delivery profiles corresponding to delivery shapes, profile segments, and polynomial expressions.
In embodiments, databases or drug libraries 510 comprising delivery profiles can enable users of computer management system 530 or infusion pump 540 to execute delivery protocols on infusion pump 540 without downloading new firmware or modifying the device executable. Generally, firmware (i.e., embedded software) contains the means to support pump programming and communication with a computer management system or central server. Typically, the operating system and communication protocols used to execute drug delivery profiles are stored on an infusion pump as nonvolatile Read Only Memory (ROM). In some embodiments, ROM can be replaced or supplemented by other components such as, e.g., Random Access Memory (RAM) and/or Flash memory. Many infusion pump systems currently available require new firmware upgrades or installation in order to execute new delivery protocols or protocols not typically executed on a particular device. In embodiments, databases or drug libraries 510 comprising delivery profiles can enable users of computer management system 530 or infusion pump 540 to execute new or non-native delivery protocols by mimicking or emulating existing infusion profiles used by various pump manufactures or healthcare providers, without a firmware upgrade or installation.
At 680, once the safety and efficacy of the delivery profile is properly verified by a healthcare provider, the delivery profile can be executed as part of a delivery protocol.
In embodiments, delivery profiles can be executed as part of TCI systems.
Various embodiments provide increased flexibility and options for intra-system and inter-system operability and functionality. As previously mentioned, profiles or underlying polynomials can have as an input, and/or be edited or altered based on, data received from other devices or systems, such as feedback from sensors or other components or devices, as permitted within applicable safety standards and limits. As such, embodiments can be used as a building block for a closed-loop or feedback-based system, including one enabling a responsive or reactive profile based on various conditions or information as they may occur in real time, are sensed, recorded, entered or otherwise obtained, and are processed and incorporated by and into the underlying polynomial and/or profile. In some embodiments, clinician approval, monitoring or other involvement can be required before any delivery changes are implemented. In still other embodiments, predictive elements can be incorporated, such as by using sensors to obtain feedback and predict future needs or events based on past feedback, performance or real-time current information. Still other predictive embodiments can use past treatment data, such as data related to patient treatment or response, to provide future therapies.
Various embodiments also can be used within or as part of various delivery methods, which can be defined sets of delivery sequences and associated rules for programming and running a method, and can include optional workflow elements. Examples of delivery methods include continuous and intermittent delivery methods. An example continuous delivery method can include several segments, including a loading segment, a main segment, optional replacement clinical bolus segment(s), and optional KVO segment(s), and can include different infusion types with different units for programming dosages (e.g., mL/hr; dose/kg/min; etc.). An example intermittent delivery method can include a main segment and optional flush segment(s), and also can include different infusion types with different units for programming dosages (e.g., mL/hr; dose/kg/min; etc.). Conventional continuous and intermittent delivery methods are hard coded to run particular combinations of segments and for each segment type.
In contrast, features and advantages of and provided by embodiments of the devices, systems, methods and techniques discussed herein relate to enabling user definition of delivery methods, profiles and segments. In embodiments, rules for a segment can be defined from a set of operating rules; the names of segments can be defined from a name rule set; inter-segment behaviors can be defined from an operating rule set; and infusion types that are available for a plan can be defined from a set of types. Advantageously, any number of sequential or parallel segments can be defined, providing a user with increased flexibility and ability to tailor a profile for a patient, setting, use, or according to some other factor or combination of factors.
Furthermore, embodiments can implement or be compatible with a variety of delivery methods, including the continuous and intermittent methods discussed above, but also others. For example, as previously mentioned some embodiments can be used in various delivery methods that integrate or resolve profiles or segments, such as those that involve multiple delivery rates sequentially or in parallel, in various different ways. Embodiments that include integration of profiles and/or segments can link the profiles or segments in logical ways and reduce the need for manual resolution, such as by clinicians or through hard programming. Several examples that include various types of integration follow.
In a “least” delivery method of integrating multiple delivery rates, the delivery at each instant is performed at the least of the set of rates. For example, if a first delivery rate is a constant rate of 1 mL/hr and a second delivery rate is a linearly increasing rate starting at 0 and ending 10 minutes later at 5 mL/hr, integrating at “least” would mean delivering at a linearly increasing rate starting at 0 and reaching 1 mL/hr after 2 minutes. Once the rate of 1 mL/hr is reached, delivery continues at that rate. An example use of this would be delivery of a substance that requires gradual increase or decrease in delivery but must never exceed a delivery rate to avoid overdosing.
In a “greatest” delivery method of integrating multiple delivery rates, the delivery at each instant is performed at the greatest of the set of rates. For example, if delivery is a constant rate of 1 mL/hr and another is a linearly increasing rate starting at 0 and ending 10 minutes later at 5 mL/hr, integrating at “greatest” would mean delivering at rate of 1 mL/hr until the linearly increasing rate passes 1 mL/hr at the 2 minute point and then linearly increasing for the remainder of the 10 minutes. An example use of this would be delivery of a substance that requires gradual increase or decrease in delivery but must never go below a minimum to avoid loss of the fluid path in the body.
Other delivery method examples include serial concatenation, including serial concatenation with smoothing or splining. Refer, for example, to
Another feature and advantage of embodiments is the ability to use the devices, systems, methods and techniques discussed herein in virtual ways, such as with a virtual pump or infusion system. A virtual pump can comprise a set of software operating on a server or computer that enables a user to test or evaluate delivery methods, profiles, segments and other features. This can be advantageous in clinical learning and educational settings, and for research purposes related to patient care, drugs, hardware and other factors. For example, researchers or clinicians can use the virtual pump to create delivery profiles and then run them through a virtual pump or multiple virtual pumps to see how the delivery profile performs on its own or how multiple delivery profiles interact. Researchers and clinicians also could use a virtual pump for simulations, testing, drug development, education of medical professionals, and for other purposes. In embodiments, the virtual pump can be configured to operate on a rules basis, accept lower or higher parameters, permit ambiguity, and otherwise run using incomplete or conflicting information, in order for a research or clinician to evaluate characteristics, performance and other factors in a highly sophisticated manner that does not affect patients, equipment or controlled substances. A variety of simulations can be run, and in embodiments the virtual pump can document the various settings and results for ease of evaluation. In still other embodiments, the data and settings underlying profiles or methods evaluated on the virtual pump and approved for implementation in actual clinical settings can be exported from the virtual pump to a server or computer where they can be made available for use on infusion pumps. Security features and settings can be implemented in the virtual pump to ensure that only authorized data is made available more broadly than on the virtual pump. In further embodiments, the virtual pump is isolated so as to not enable sharing or comingling of data with that of live pumps.
It is to be appreciated and understood that methods, systems, and software for downloading, editing, and/or integrating drug delivery profiles or segments of profiles, such as have been described by example or otherwise contemplated herein, may allow for delivery of arbitrarily complex patterns, as the profiles and their subsequent deliveries are conducted in bursts or stages. Therefore, delivery based on what will be due by an arbitrary point in time makes complex profiles easier to deliver.
It is further to be appreciated and understood that any of the aforementioned delivery profiles or segments of delivery profiles can be stored and/or performed in the infusion pump itself or a computer server, in the pump internally or separately or otherwise remotely from the pump. Further, it is to be appreciated that the aforementioned delivery profiles or segments of delivery profiles can be created by or with outside software or systems and subsequently downloaded to or integrated with the systems and software described herein.
For example, in an embodiment a database comprises at least one delivery profile executable as part of a medical device delivery protocol, wherein the at least one delivery profile comprises at least one profile segment integrated to form the at least one delivery profile. The at least one delivery profile executable as part of a medical device delivery protocol can be used to control, or cause to operate, a medical device, such as an infusion pump. In embodiments, providing at least one delivery profile to a medical device, such as an infusion pump, can configure or reconfigure the medical device to provide a therapy to a patient, such as through infusion of a fluid, drug, infusate or other medical material deliverable by the medical device according to the at least one delivery profile. The at least one delivery profile and/or the at least one profile segment can be created or programmed at the device, or can be communicated, partially or wholly, to the pump from a processor, computer, server, medical device, handheld device, and/or other external device via a communications network or device, and wired, wirelessly or a combination thereof. Similarly, a delivery profile executable on an electronic device as part of a medical device delivery protocol, the delivery profile comprising at least one profile segment integrated to form the delivery profile, can configure or reconfigure the medical device and/or cause the medical device to operate to provide a therapy or treatment to a patient by delivering a medical fluid or other substance to a patient according to the delivery profile.
In embodiments, an infusion pump comprising programmable circuitry configured to download at least one delivery profile or at least one profile segment; integrate the at least one delivery profile or the at least one profile segment to form an executable delivery profile; and execute a medical device delivery protocol comprising the executable delivery profile on the infusion pump, can operate to deliver a therapy or treatment to a patient when executing the medical device delivery protocol. The database and infusion pump mentioned above can operate in embodiments as part of a medical device system that also configures or reconfigures the infusion pump and cause the infusion pump to operate and deliver a therapy or treatment to a patient.
In embodiments, a method of creating a varied segmentable delivery profile can comprise accessing a database comprising at least one segmentable delivery profile or at least one profile segment; transferring the at least one segmentable delivery profile or the at least one profile segment to an electronic device; and integrating the at least one segmentable delivery profile or the at least one profile segment to create a second delivery profile. This and other methods also can include executing the second delivery profile as part of a delivery protocol of the infusion pump to cause the infusion pump to operate and provide a therapy or treatment to a patient by delivering a fluid, drug, infusate or other material to the patient according to the delivery protocol.
These examples are given according to only some of many possible embodiments, keeping in mind that some embodiments relate to virtual devices or machines implemented using computers, processors, medical devices, or other devices that enable a user to cause a medical device to operate virtually via one of these other devices or machines for the purposes of simulating or testing operation of the medical device.
It should also be appreciated that the exemplary embodiment or exemplary embodiments are only examples, and are not intended to limit the scope, applicability, or configuration of the invention in any way. Rather, the foregoing detailed description will provide those skilled in the art with an enabling disclosure for implementing the exemplary embodiment or exemplary embodiments. It should be understood that various changes can be made in the function and arrangement of elements without departing from the scope of the subject matter hereof as set forth in the appended claims and the legal equivalents thereof. For example, in embodiments described with a syringe-type infusion pump, it is to be understood that an ambulatory type pump could have been alternatively employed.
The embodiments above are intended to be illustrative and not limiting. Additional embodiments are within the claims. Although subject matter hereof has been described with reference to particular embodiments, workers skilled in the art will recognize that changes may be made in form and detail without departing from the spirit and scope of the subject matter.
Various modifications to subject matter hereof may be apparent to one of skill in the art upon reading this disclosure. For example, persons of ordinary skill in the relevant art will recognize that the various features described for the different embodiments of the invention can be suitably combined, un-combined, and re-combined with other features, alone, or in different combinations, within the spirit of the subject matter. Likewise, the various features described above should all be regarded as example embodiments, rather than limitations to the scope or spirit of the subject matter. Therefore, the above is not contemplated to limit the scope of the subject matter.
For purposes of interpreting the claims for subject matter hereof, it is expressly intended that the provisions of Section 112, sixth paragraph of 35 U.S.C. are not to be invoked unless the specific terms “means for” or “step for” are recited in a claim.
This application claims the benefit of U.S. Provisional Patent Application No. 61/949,667 filed Mar. 7, 2014, which is incorporated herein by reference in its entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2015/018462 | 3/3/2015 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
61949667 | Mar 2014 | US |